NEW YORK (GenomeWeb News) – Autoimmune molecular diagnostics firm Ignyta said this week that it has raised $5.5 million in an expanded Series B equity financing round.

Additionally, the firm received a $500,000 capital term loan in June 2012 from Silicon Valley Bank bringing the total in Series B-related proceeds to $6 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.